Arcutis Biotherapeutics, Inc. (ARQT)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

2945 TOWNSGATE ROAD WESTLAKE VILLAGE, CA 91361

Arcutis Biotherapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on developing treatments for unmet needs in immune-mediated diseases and conditions. Arcutis Biotherapeutics serves medical sector in the United States.

Data as of 2020-05-30
Market Cap1.28 Billion Shares Outstanding38.155 Million Avg 30-day Volume58.974 Thousand
P/E Ratio Dividend Yield EPS-1.98
Price/Sales Price cash flow ratio Price free cash flow ratio-20.1
Book Value6.34 Price to Tangible Book4.73 Alpha
Short Interest Ratio % Short Interest to Float R-squared
BETA 52-week High/Low40.88 / 17.1 Stddev
View SEC Filings from ARQT instead.

View recent insider trading info

Funds Holding ARQT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ARQT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TURNER JOSEPH L

  • Director
0 2020-05-21 2

GILBERT HALLEY E

  • Director
0 2020-05-01 2

WATANABE TODD FRANKLIN PRESIDENT AND CEO

  • Officer
  • Director
777,565 2020-03-13 4

WELGUS HOWARD G. CHIEF MEDICAL OFFICER

  • Officer
184,983 2020-03-12 4

SUN RICKY

  • Director
0 2020-03-10 2

HERON PATRICK J

  • Director
  • 10% Owner
5,009,219 2020-03-03 3

ESTES DANIEL

  • Director
0 2020-02-27 2

CHAUDHURI BHASKAR

  • Director
0 2020-02-27 3

SILVERSTEIN JONATHAN

  • Director
  • 10% Owner
0 2020-02-27 3

OSBORNE DAVID W CHIEF TECHNICAL OFFICER

  • Officer
404,235 2020-02-27 3

SMITHER JOHN W CHIEF FINANCIAL OFFICER

  • Officer
  • Director
108,965 2020-02-27 2

LOCK KENNETH A. CHIEF COMMERCIAL OFFICER

  • Officer
9,000 2020-02-27 2

TURNEY PATRICIA A. SENIOR VP, MANUFACTURING

  • Officer
9,000 2020-02-27 2

BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC

BAIN CAPITAL LIFE SCIENCES PARTNERS, LP

BAIN CAPITAL LIFE SCIENCES FUND, L.P.

BCIP LIFE SCIENCES ASSOCIATES, LP

KOPPEL ADAM

SCHWARTZ JEFFREY LAWRENCE

  • 10% Owner
3,979,292 2020-02-04 2

FRAZIER LIFE SCIENCES VIII, L.P.

FHM LIFE SCIENCES VIII, L.P.

FHM LIFE SCIENCES VIII, L.L.C.

TOPPER JAMES N

  • 10% Owner
10,542,790 2020-02-04 3

ORBIMED ADVISORS LLC

ORBIMED CAPITAL LLC

ORBIMED CAPITAL GP VII LLC

  • Director
  • 10% Owner
5,232,738 2020-02-03 2

ASAM ALEXANDER

  • Director
0 2020-01-30 1

FRAZIER LIFE SCIENCES VIII, L.P.

FHM LIFE SCIENCES VIII, L.P.

FHM LIFE SCIENCES VIII, L.L.C.

  • 10% Owner
509,032 2020-01-30 3

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

GILBERT HALLEY E - Director

2020-05-01 A 37,500 a 37,500 0.00 direct

Elevate your investments